Psychophysiologic Symptom Relief Therapy for Post-Acute Sequelae of Coronavirus Disease 2019
Long COVID (post-acute sequelae of COVID-19, or PASC) affects 4-35% of infected individuals and causes significant disability and economic burden. However, many patients experience persistent symptoms despite having only mild-to-moderate acute infection and no detectable organ damage on standard testing. Current understanding of PASC's underlying mechanisms remains incomplete, though proposed causes range from microclots to immune dysfunction. This study investigates whether psychophysiologic factors—where psychological processes produce physical symptoms—may explain PASC in patients without identified organ injury, similar to post-traumatic stress disorder or other established psychophysiologic syndromes.
The researchers conducted a 13-week interventional study with 23 adults (median age 42.6 years) experiencing persistent PASC symptoms for at least 12 weeks without organ injury. Participants received Psychophysiologic Symptom Relief Therapy (PSRT), a hybrid program combining 4 weeks of psychophysiologic education, desensitization, and emotional awareness exercises with 9 weeks of mindfulness-based stress reduction. Validated questionnaires measuring somatic symptoms, fatigue, pain, dyspnea, anxiety, and "brain fog" were administered at baseline and 4, 8, and 13 weeks. The intervention was delivered virtually by a physician and mind-body expert.
Results demonstrated substantial clinical improvements across all measured domains. The primary outcome—somatic symptom burden measured by the Somatic Symptom Scale-8—decreased by 8.5 points at 4 weeks, 9.4 points at 8 weeks, and 10.9 points at 13 weeks (all p<0.001), representing a median 55% reduction from baseline. Secondary outcomes similarly improved: fatigue severity decreased by median 20 points, dyspnea by 27 points, pain intensity by 2.4 points, and pain anxiety by 28.6 points. Notably, 57% of participants initially believed exercise worsened symptoms, but only 4% held this belief by study end, with corresponding increases in physical activity levels.
These findings suggest that PSRT may effectively reduce symptom burden in PASC patients without identifiable organ damage, possibly by breaking conditioned symptom responses through psychophysiologic education and desensitization. However, clinicians should recognize important limitations: the study lacked a control group, had selection bias toward participants open to mind-body interventions, and included only 23 participants. The findings apply specifically to mild-to-moderate COVID-19 without organ injury and should not be generalized to PASC with documented damage (lung fibrosis, myocarditis, etc.). Long-term follow-up is needed to determine symptom durability after intervention completion.